Dr. Hönle AG reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported sales was EUR 29.17 million compared to EUR 27.34 million a year ago. Net loss was EUR 0.724 million compared to net income of EUR 0.129 million a year ago.
For the nine months, sales was EUR 95.46 million compared to EUR 84.98 million a year ago. Net income was EUR 4.65 million compared to EUR 4.78 million a year ago. Basic earnings per share from continuing operations was EUR 0.77 compared to EUR 0.79 a year ago. Diluted earnings per share from continuing operations was EUR 0.77 compared to EUR 0.79 a year ago.